Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alcohol and Steatotic Liver Disease Exhibit Divergent Associations with High Plasma Small Dense LDL-C Concentration.

The Journal of clinical endocrinology and metabolism·2026
Same author

Cross-Sectional Association of Lipoprotein(a) Levels With Vascular Complications and Related Parameters in a Japanese Type 2 Diabetes Cohort.

Journal of atherosclerosis and thrombosis·2026
Same author

Response to letter to the editor by Liu and colleagues.

Journal of clinical lipidology·2026
Same author

Small Dense Low-Density Lipoprotein Cholesterol Predicts Long-Term Coronary Artery Disease Recurrence in Patients Without Metabolic Dyslipidemia.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

The effect of luminance on visual acuity measurement in eyes with epiretinal membrane.

Japanese journal of ophthalmology·2026
Same author

Longitudinal change in anterior chamber depth and its determinants: a median 4.9-year follow-up of 2,247 Japanese adults.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026

Related Experiment Video

Updated: May 21, 2026

Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy
09:37

Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy

Published on: August 15, 2014

[Apolipoprotein B and small, dense LDL-C].

Yasuki Ito1

  • 1Reagent R&D Department, Denka Seiken Co., Ltd. Gosen, 959-1695, Japan. y_ito@denka-seiken.co.jp

Rinsho Byori. the Japanese Journal of Clinical Pathology
|June 13, 2012
PubMed
Summary

Apolipoprotein B-100 (apo B-100) and small, dense LDL-C (sdLDL-C) are key markers for coronary heart disease (CHD) risk. Measuring both provides deeper insights into CHD causes and guides personalized treatment strategies.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Chemistry
  • Lipidology

Background:

  • Coronary heart disease (CHD) risk is significantly influenced by lipid profiles.
  • Apolipoprotein B-100 (apo B-100) and small, dense LDL-C (sdLDL-C) are established biomarkers for CHD.
  • Elevated levels of these markers are associated with conditions like familial hypercholesterolemia, familial combined hyperlipidemia, diabetes mellitus, and metabolic syndrome.

Purpose of the Study:

  • To evaluate the clinical utility of apo B-100 and sdLDL-C as risk markers for CHD.
  • To investigate the differential diagnostic value of apo B-100 and sdLDL-C in various hyperlipidemic conditions.
  • To determine if combined assessment of apo B-100 and sdLDL-C offers enhanced clinical information for CHD risk stratification.

Main Methods:

More Related Videos

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Related Experiment Videos

Last Updated: May 21, 2026

Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy
09:37

Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy

Published on: August 15, 2014

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

  • Apo B-100 was measured using a fully automated turbidimetric immunoassay.
  • SdLDL-C was quantified via an enzymatic homogeneous assay on an automated analyzer.
  • Comparative analysis of apo B-100 and sdLDL-C levels was performed across different patient groups.

Main Results:

  • Both apo B-100 and sdLDL-C are independently associated with increased CHD risk.
  • Distinct patterns of apo B-100 and sdLDL-C elevation were observed: familial hypercholesterolemia showed higher apo B-100, while diabetes mellitus and metabolic syndrome showed higher sdLDL-C.
  • Familial combined hyperlipidemia exhibited similar levels for both markers.
  • Combined assessment revealed nuanced differences in marker tendencies across conditions.

Conclusions:

  • Measuring both apo B-100 and sdLDL-C provides complementary information for CHD risk assessment.
  • The differential elevation patterns of these markers can help elucidate the underlying cause of CHD.
  • Combined analysis enhances clinical utility, potentially leading to more targeted and effective patient treatments.